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doi:10.1016/j.ejvs.2009.01.013Abstract Background: Major limb amputation is often required by patients with a limited
capacity to tolerate post-operative complications. Amputation stump infection is common
and may necessitate re-amputation, potentially exposing a vulnerable patient to further
serious complications. Effective antibiotic strategies should be employed to reduce wound
infection after major amputation.
Methods: Online databases were searched to identify studies regarding reduction in wound
infection following major limb amputation. Only four randomised studies were identified
comparing antibiotic prophylaxis with control; a further three evaluated the efficacy of
specific antibiotics. Study design, end-points and outcome data were recorded. The data were
too heterogeneous for formal meta-analysis.
Results: Prophylactic antibiotics significantly reduced rates of stump infection in all studies,
and were associated with a reduced rate of re-amputation in one. Where investigated, the
type of antibiotic did not affect rates of infection. In non-randomised studies, infection with
methicillin resistant Staphylococcus aureus (MRSA) increased the risk of complications and
post-operative death.
Conclusion: It is agreed that prophylactic antibiotics are part of the standard of care for ampu-
tation surgery, and this is supported by limited, mostly historical-controlled data. Evolution of
the bacterial threat means that future studies should assess the role and type of prophylaxis
for patients with existing bacterial colonisation or infection.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.8454 226190; fax: þ44 08454
i.co.uk (J.J. Earnshaw).
ty for Vascular Surgery. PublisheIntroduction
Major limb amputation is the devastating end stage of
advanced peripheral vascular disease, and often follows
prolonged attempts at limb salvage. The most importantd by Elsevier Ltd. All rights reserved.
Prevention of Infection after Major Limb Amputation 697local complication after amputation is failure of the stump
to heal. This may be the result of continued ischaemia, or
infection caused by wound contamination by pathogenic
bacteria (often there is an element of both). Defining the
appropriate level of amputation with respect to the
remaining blood supply in the leg is a major factor in
ensuring primary healing, but will not be considered further
here. The aim of this review is to summarise the literature
concerning the role of antibiotic prophylaxis in the
prevention of amputation stump failure.
Patients who need major limb amputation are
frequently elderly with numerous medical co-morbidities,
and represent a high-risk group for surgical intervention,
with decreased capacity to tolerate complications. They
often have many patient-related risk factors for developing
surgical site infection, including diabetes mellitus, old age,
smoking and bacterial colonisation.1 As a consequence of
their co-morbidities, these patients are often exposed to
the health care environment where they may become
colonised with pathogenic bacteria. For example, patients
recently exposed to a health care environment are twice as
likely to be colonised with methicillin resistant Staphylo-
coccus aureus (MRSA).2,3 It is not unusual for potential
amputees to come from residential care facilities where
MRSA colonisation is common.4,5 In addition, the presence
of skin ulceration, necrosis and gangrene, often the indi-
cation for limb amputation, is recognised as a risk factor for
developing MRSA-related complications in colonised
patients.6
The consequences of infection following major limb
amputation may include the need for wound revision or re-
amputation at a higher level. This increases hospital stay,
and also potentially increases the rate of secondary post-
operative complications, which may include acute
myocardial infarction, pneumonia and even death, or late
complications such as poor long-term mobility and inde-
pendence. Minimising the risk of stump infection after
major amputation therefore reduces both hospital stay and
secondary morbidity.
The aim of this review was to summarise the available
literature on antibiotic prophylaxis in leg amputation
surgery, evaluate the importance of the available trials and
then to suggest the possible direction for future research.Methods
Studies concerning wound infection after major limb
amputation were identified by performing a literature
search on Medline, PubMed, Google Scholar and The
Cochrane Library, using the keywords major limb amputa-
tion with the Boolean operator ‘AND’ wound infection
‘AND’ antibiotic prophylaxis. The search was exploded
using the ‘related articles’ term in PubMed. No restrictions
were put on language or references starting date, and all
identified studies were included. The reference lists of
published studies were also scrutinised in order to identify
any other studies that could be included. All studies iden-
tified were reviewed and data pertaining to recorded end-
points and their frequency were recorded. The quality of
the study design and reporting was included as part of the
analysis.End-points after major limb amputation
To decide which strategies could be useful in reducing
infection after major limb amputation, peer reviewed,
comparative data on clinically important end-points were
analysed from suitably designed trials. As a minimum
requirement, the key end-points after major limb ampu-
tation should have included: rate of primary wound healing,
rate of infected and non-infected wound necrosis, re-
operation for wound debridement and re-amputation
(including the level at which this was performed) and
mortality, both wound and non-wound related. Other end-
points sought were duration of post-operative hospital stay
and adverse events relating to the treatment.
Analysis
The available literature was reviewed to look for evidence
supporting measures designed to reduce stump infection
following major limb amputation. Ideally meta-analysis
should be used to collate the results of randomised trials,
however, the available trials were too heterogeneous and
diverse for this to be valid statistically. It was therefore
decided simply to perform a summation analysis without
formal statistical review.Results
Antibiotic prophylaxis
There were four studies that compared patient outcome
following major limb amputation with, or without antibiotic
prophylaxis (Tables 1 and 2). Two were prospective,
controlled trials,7,8 but only one described treatment
allocation8 and neither was blinded. The other studies were
randomised trials,9,10 of which only one was blinded or
described the method of allocation to treatment.10 In three
studies8e10 amputation was performed by an orthopaedic
surgeon, and in the fourth by a vascular surgeon.7 Three
studies reported data from a single institution,7e9 the
fourth included data from seven separate hospitals.10 This
study stated that amputations followed the usual regimen
for the individual department, and it was evident from
their description of both operative procedure and post-
operative wound care that the regimens of the individual
departments were different. Further, their data also
included 16 through knee amputations, a technique not
used in all studies.7 Although though knee amputations
were included by Moller and Krebs,8 they did not state how
many were done, nor indeed the number of the different
amputations at each level.
The mean age of the patients in three of the studies was
comparable8e10 but in the study by Huizinga et al. it was
lower.7 The indications for amputation may have varied,
however, these appeared to be similar in all the studies,
albeit that amputation for ‘‘arteriosclerosis’’ reported in
one study10 lacked the more specific indications cited in the
others. Huizinga et al.7 included amputations for infected,
non-healing wounds after previous amputation, whereas
the other studies included primary amputations only.
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698 J. McIntosh, J.J. EarnshawOnly one study employed a placebo in the patients who
did not receive antibiotics.10 The antibiotics used are
summarised in Table 2. All studies recorded primary wound
healing and wound infection as end-points; two recorded
rates of dry necrosis8,10 and three recorded rates of re-
amputation,8e10 with Sonne-Holm et al.10 and Norlin et al.9
recording the level at which this occurred. No other end-
points were recorded.
Prophylactic antibiotics significantly reduced the rate of
wound infection in all the studies (amoxicillin, P< 0.01,
amoxicillin and flucloxacillin, P< 0.005, amoxicillin and clav-
ulanic acid, P< 0.005,7 P< 0.01,8 P< 0.001,9 P< 0.00510).
Rates of dry necrosis requiring re-amputation were greater
after antibiotic use in one study8 (4/27, 14.8% vs 1/23, 4.3%,
no statistical analysis), however, no re-amputations were
needed for infected necrosis in the prophylaxis group
compared with seven in the control group (no statistical
analysis). In another study, dry necrosis did not differ signifi-
cantly between groups,10 but the re-amputation rate was
significantly higher after placebo (21/75, 28% vs 7/77, 9%,
P< 0.005) and was more commonly performed at a higher
level, irrespective of antibiotic use. This concurred with
re-amputation level data from another study.9
All the antibiotics reduced the rates of clinical wound
infection and positive wound culture swabs, except flu-
cloxacillin in the study reported by Huizinga et al.7 There
was an obvious discrepancy in the control group in the
latter study, however, as the authors reported that 13 out
of 26 controls received benzyl penicillin (500 mg intrave-
nous, QDS for 48 h) due to the high rate of isolation of
Clostridium species from wound swabs in the first 13
patients from this group. Although the authors concluded
that this did not affect the homogeneity of the control
group, patients who received benzyl penicillin should have
been excluded from the study in the same way that patients
who had received antibiotics in the 48 h before surgery for
other indications were excluded. This study also compared
flucloxacillin with other antibiotics used in the investiga-
tion, and reported that only the combination of amoxicillin
and clavulanic acid showed a significant advantage in
reducing clinical wound infection and positive wound
culture swabs (P< 0.005 for both parameters). One of the
co-authors of the study was based at the pharmaceutical
company acknowledged for supplying the antibiotics for the
study, which clearly represents a potential conflict of
interest, particularly as the study was not blinded.Trials of different antibiotics
Three studies compared the efficacy of different prophy-
lactic antibiotics for major limb amputation (Table 3). Two
compared broad spectrum penicillins with broad spectrum
cephalosporins (methicillin vs cephalothin,11 and penicillin
G vs cefuroxime12), whilst a third compared members of the
penicillin group (benzyl penicillin vs amoxicillin and clav-
ulanic acid13). The first two studies were performed after
the studies discussed in the previous section, and recorded
end-points that included wound revision and level of re-
amputation, and post-operative death.
The first two studies were prospective, randomised trials
with acceptable patient recruitment.11,12 Neither reported
Table 2 Indication, antibiotic regimens, operation, end-points and result summary following major limb amputation
References Indication for
amputation
Antibiotic
regimens
Site of
amputation
End-points
recorded
Results Summary
(compared to
control)
BKA TKA AKA
Norlin et al.9 Ischaemia IV cefotaxime 2 g
(20 min pre-op & 2
doses post op)
Control 11 3 5 Wound infection Significantly
reduced
Cefotaxime 13 3 3 Re-amputation
rate
Reduced
Huizinga et al.7 Infected non-
healing ulceration
IV Fl 500 mg QDS Control 15 11 Wound infection Significantly
reduced by all
antibiotics
except Fl
Infected gangrene IV Am 500 mg QDS Fl 19 7
Infected non-
healing of
previous
amputation
wound
IV Fl/Am 500 mg
QDS (30 min pre-
op & QDS for 48 h)
Am 21 10
PO Am 500 mg and
Ca 250 mg (2 h
pre-op & TDS for
48 h)
Fl/Am 18 14
Am/Ca 15 15 Am/Ca
combination
reported
as significantly
better than
other regimes
Total 88 57
Moller and Krebs8 Infected non-
healing ulceration
IV methicillin 1 g
(30 min pre-op &
QDS for 24 h)
Not recorded Wound infection Significantly
reduced
Gangrene Dry necrosis Increased (no
statistics)
Rest pain Re-amputation
rate
Reduced
Sonne-Holm
et al.10
Arteriosclerosis IV cefoxitin 2 g
(Induction & QDS
for 24 h)
Control 38 10 27 Wound infection Significantly
reduced
Cefoxitin 43 6 28 Dry necrosis No difference
Total 81 16 55 Re-amputation
rate (3/12)
Significantly
reduced
Fl, Flucloxacillin, Am, Amoxicillin, Ca, Clavulanic acid, BKA, below knee amputation, TKA, through knee amputation, AKA, above knee
amputation.
Prevention of Infection after Major Limb Amputation 699any significant differences in any of the end-points. For
example, Friis12 reported wound infection rates of 12.6%
(20/158) with penicillin G and 17.4% (27/155) with cefur-
oxime (P> 0.05); whilst rates of re-amputation reported by
Thomsen et al11 were 18.2% (16/88) after cephalothin and
12.8% (11/86) after methicillin (PZ 0.3094). One criticism
of the study by Friis12 is that some of the patients received
antibiotics in the 48 h before surgery for other indications.
Data on these patients were presented separately,
however, and the results appeared similar between the
groups, although no statistical analysis was done.
The third of these studies13 predated those in the
previous section, and only reported wound infection as an
end-point. Benzyl penicillin was compared to the combi-
nation of amoxicillin and clavulanic acid; the authors
reported significantly higher rates of wound infection with
benzyl penicillin (10/13, 76.9% vs 4/31, 12.9%, P< 0.001).
Whilst the benefit of a broader antimicrobial spectrum may
not be a surprise, this study also included a number of
transmetatarsal and phalangeal amputations, and was
therefore more heterogeneous than other populationsstudied. Additionally, as noted in the previous study from
this group, a participating co-author was affiliated to the
pharmaceutical company who produced and supplied the
antibiotics for the study.
Another study was identified that compared cephradine
with cefuroxime in 41 patients undergoing major limb
amputation.14 These were, however, reported as part of
a larger study of vascular procedures that included other
elective and emergency vascular reconstructions. Further,
the authors did not state if the amputation was a primary
procedure or whether it followed unsuccessful revascular-
isation. Wound infection was the only end-point reported
after amputation, and in keeping with previous studies11,12
the rates of wound infection were similar in both groups
(2/19, 11%, cephradine vs 3/15, 15% cefuroxime, no
statistical analysis).
A further study was identified15 that compared
pre-operative metronidazole and neomycin (with no post-
operative antibiotics) against post-operative oral
penicillin V. The rationale of this study was that the
pre-operative regimen might reduce contamination with
Table 3 Published studies comparing efficacy of specific antibiotics and end-points in major limb amputation
References Year Country Study type N Comparison End-points recorded Results summary
Thomsen et al.11 1990 Denmark Prospective
randomised
trial
174 Methicillin vs
cephalothin
Primary healing No significant differences
in any end-pointsDry necrosis
Infected necrosis
Wound revision
Re-amputation
(level defined)
Friis12 1987 Denmark Prospective
trial
457 Penicillin G
vs cefuroxime
Primary healing No significant differences
in any end-pointsDry necrosis
Infected necrosis
Wound revision
Re-amputation
(level defined)
Death (wound or
non-wound related)
Huizinga et al.13 1983 South
Africa
Prospective
trial
44 Benzyl penicillin
vs amoxicillin and
clavulanic acid
Wound infection Wound infection rate higher
with benzyl penicillin
compared to amoxicillin and
clavulanic acid.
Table 4 Infecting organisms in published studies relating to wound infection following major limb amputation
References Year Country Comparison Infecting micro-organism(s) reported
Norlin et al.9 1990 Sweden No antibiotics vs cefotaxime 2/4 (50%) Staphylococcus aureus, 2/4 (50%) Gram
negative organisms.
Thomsen et al.11 1990 Denmark Methicillin vs cephalothin 18/25 (72%) Staphylococcus aureus, 3/25 (12%) Gram
negative organisms, 4/25 (16%) undefined
(1 positive swab for Clostridium perfringens without
clinical evidence of infection).
Friis12 1987 Denmark Penicillin G vs cefuroxime 10/47 (21%) Staphylococcus aureus, 1/47 (2%)
Clostridium perfringens.
Huizinga et al.7 1986 South
Africa
No antibiotics
vs flucloxacillin, amoxycillin,
flucloxacillin & amoxicillin
and amoxicillin and clavulanic
acid
Proteus mirabilis, Proteus vulgaris, Pseudomonas
aeruginosa, Streptococcus faecalis, Acinetobacter
calcoaceticus anitratum, Bacteroides
fragilis, Bacteroides melaninogenicus.
No numerical
data given
Moller and Krebs8 1985 Denmark No antibiotics vs methicillin 6/8 (75%) Staphylococcus aureus, 2/8 (25%)
Streptococcus faecalis, 1/8 (13%) Clostridium
perfringens, Escherichia coli, Pseudomonas
and Enterobacter.
Sonne-Holm et al.10 1985 Denmark Placebo vs cefoxitin Authors state
that Staphylococcus aureus and Clostridium
perfringens caused most
infections, but no numerical
data given.
Huizinga et al.13 1983 South
Africa
Benzyl penicillin
vs amoxicillin and clavulanic
acid
1/13 (8%) Proteus mirabilis, other
infecting organisms undefined.
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authors previously found to be associated with wound
infection. Only 10 patients were enrolled in the study,
which was concluded prematurely due to a high rate of
Clostridial wound infections in the patients who had pre-
operative metronidazole and neomycin. These two studies
added little to the evidence presented, and are only cited
for completeness.
Infecting micro-organisms
Where the organism was reported, wound infection was
most frequently caused by S. aureus, which accounted
for between 21% (10/47) and 75% (6/8) of infec-
tions8,9,11,12(Table 4). Another study cited this organism to
be the cause for the majority of infections without giving
exact numerical data.10 Clostridium perfringens was iden-
tified as an occasional infecting organism in two studies: 2%
(1/47) and 13% (1/8).8,12 This pathogen was also identified
on a post-operative wound swab in another study, but
without clinical evidence of infection.11
Gram negative bacteria caused between 8% (1/13) and
50% (2/4) of wound infections in some studies.8,9,11,13 They
were also recognised as a significant cause in another study,
but without exact numbers.7
Methicillin resistant S. aureus
Increasingly, MRSA is being identified as a major problem in
vascular surgery, particularly in the United Kingdom. It is
not unusual for patients to need amputation who have
either colonisation, or frank infection due to MRSA.
Unsurprisingly, as yet there are no controlled studies that
compare antibiotic prophylaxis in either of these groups.
One non-randomised cohort study examined the effi-
cacy of teicoplanin prophylaxis in 29 patients that had
either colonisation or wound infection before major limb
amputation.16 There was primary healing after 22 proce-
dures (76%); no patient with MRSA colonisation developed
an MRSA wound infection postoperatively. Seven patients
developed post-operative amputation stump infection;
five of these were caused by MRSA, three of whom had
active MRSA infection at the time of amputation. Pre-
operative MRSA infection significantly increased the rate
of post-operative MRSA stump infection (PZ 0.007), and
the risk of re-amputation (PZ 0.009), and also increased
post-operative hospital stay (PZ 0.0074). This was in
keeping with other published data,17 where patients with
MRSA (colonisation or infection) were found to have spent
longer in hospital before amputation (PZ 0.0038). The
authors of this study concluded that patients with MRSA
colonisation should be considered separately from those
with active infection preoperatively, and that their
management should be different. They suggested that
teicoplanin prophylaxis alone might be adequate in
patients colonised with MRSA at the time of surgery, but
that active MRSA infection should be treated before major
limb amputation, if possible, since it was associated with
a higher risk of complications .17 The adverse association
of post-operative MRSA stump with outcome was rein-
forced in another study where it resulted in a significantreduction in the rate of primary healing (P< 0.05) and
a significantly increased mortality rate compared to those
who did not get post-operative MRSA infection18
(P< 0.001).
Conclusions
This review has highlighted the paucity of studies exam-
ining strategies to reduce wound infection after major limb
amputation; indeed many existing studies have identifiable
confounding factors. This finding is similar to the literature
on antibiotic prophylaxis for vascular reconstructions,
where the evidence is often historical and potentially
flawed. Yet the findings were similar, that antibiotic
prophylaxis can reduce the rate of post-operative infec-
tion.19 It is highly unlikely that larger contemporary
controlled trials will be undertaken to address these defi-
ciencies, since clinicians generally agree about the need for
antibiotic prophylaxis in patients undergoing major limb
amputation and vascular reconstruction. In addition, many
patients facing amputation have active sepsis, and have
had recent, often multiple courses of antibiotics. It is
generally agreed that patients with ongoing sepsis require
extended therapeutic antibiotic treatment. The studies
assessed here included patients with end stage vascular
disease without active sepsis, where prophylactic antibi-
otics reduced the rate of stump infection after major limb
amputation,7e10 and they reduced the rate of re-amputa-
tion in one study.10 In contrast, the type of antibiotic had
no significant effect on wound infection.11e13
The value of these largely historical studies is limited not
just by their poor design, but also by changes in the
microbiological threat which now faces patients undergoing
vascular surgery. In the identified studies, antibiotic
prophylaxis for amputations was directed primarily towards
preventing infections with Clostridium sp, yet in the
studies, S. aureus was the major infecting organism.8,10e12
However, the relentless rise in MRSA colonisation and
infection in health care settings has established this
organism as the new major threat, and one which must be
considered before deciding on prophylaxis for patients
undergoing any vascular surgical procedure. MRSA is the
most commonly isolated organism from all surgical site
infections,20 and now the commonest cause of serious
vascular wound and graft infection in the United
Kingdom.21 Rates of MRSA colonisation approaching 50%
have been reported in patients undergoing amputation,16
and post-operative MRSA wound infections in this patient
group have been shown to confer a poor outcome.16,18
For these reasons, identifying patients with MRSA
preoperatively is crucial so that eradication of colonisation
and active infection may be attempted. This strategy is
supported by published evidence that it can reduce both
surgical site and overall MRSA infections on surgical wards
and in an intensive care unit.22,23 A study in orthopaedic
patients has also shown that the use of intranasal mupirocin
reduced the rate of MRSA infection.24
Despite the lack of evidence from controlled trials,
contemporary guidelines suggest that patients colonised
with MRSA should have an attempt at eradication before
surgery, where clinical circumstances permit.25,26
702 J. McIntosh, J.J. EarnshawIntranasal mupirocin is recommended in patients planned
to undergo surgery with a high risk of major morbidity,
which would clearly include major limb amputation.
Consideration should be given to remove necrotic tissue
infected with MRSA before amputation, and treating
cellulitis with appropriate antibiotics.20 Identification also
allows such patients to be subject to other strategies
directed at reducing dissemination of MRSA in hospital,
such as nursing them in a side room and placing them last
on an operating list.
Although the use of prophylactic antibiotics is not
controversial,27 the actual drug employed and the duration
of treatment remain open to debate. To some extent this
will depend on the local microbiological flora in each
hospital, and the level of MRSA. In patients known to have
MRSA colonisation or infection, this should include teico-
planin or vancomycin. The latter drugs may be appropriate
in hospitals with a high prevalence of MRSA, even if pre-
operative swabs are negative for MRSA. The limited
evidence that exists suggests that a broad spectrum anti-
biotic should be included (e.g. co-amoxiclav); it is probably
not sufficient to use flucloxacillin alone. The duration of
prophylaxis also remains controversial, but a total of three
perioperative doses is probably adequate. A recent non-
randomised study has suggested that a prolonged course of
antibiotics for five days increased the chance of primary
healing and reduced hospital stay.28 There remains
a paucity of published data on antibiotic prophylaxis
specifically against MRSA in major limb amputation, and it
has been acknowledged that further evaluation in this area
is required.16,20
Vascular surgeons will agree that there are many factors
that can affect the healing of an amputation stump. Careful
surgery, meticulous tissue handling, accurate skin apposi-
tion and effective dressings all play a part. Cochrane meta-
analysis was unable to identify a type of incision (skew flap
or long posterior flap) that conferred improved wound
healing.29 A number of trials have suggested that the use of
a rigid stump dressing improves healing.30 The present
study has confirmed that perioperative antibiotic prophy-
laxis is also an evidence-based measure that can reduce the
rate of wound failure. Recommendations concerning indi-
vidual antibiotics are hampered by the historical nature of
the information about the bacteria involved. An effective
programme of surgical site surveillance in amputation
surgery would provide information that could guide future
research.
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